MHRA Class 2 Medicines Recall: Olopatadine USV 1mg/ml eye drops (USV UK Limited)
Class 2 Medicines recall: Olopatadine USV 1mg/ml eye drops (USV UK Limited)
Drug alert number: EL (22) A/17
Date issued: 11th April 2022
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for:
Olopatadine USV 1mg/ml eye drops (USV UK Limited) PL 32870/0055
USV UK Limited are recalling the affected batches as a precautionary measure due to out of specification
results for impurities during routine stability testing. The company’s investigation is on-going.
| Batch Number | Expiry Date | Pack Size | First Distributed |
| 35000201 | 07/2023 | 5ml | 14 July 2021 |
| 35000202 | 07/2023 | 5ml | 27 July 2021 |
| 35000203 | 07/2023 | 5ml | 5 August 2021 |
| 35000204 | 07/2023 | 5ml | 29 November 2021 |
| 35000206 | 07/2023 | 5ml | 23 July 2021 |
Advice for healthcare professionals
Stop supplying the above batches immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
Full drug alert can be viewed here.
Company contacts for further information
For more information, medical or supply enquiries, please contact info@ennogen.com
